ACORN BIOVENTURES — 2022 Investments
3 investments dated 2022 · listed companies and verified rows first · show all
Liquid Instruments develops Moku, a reconfigurable integrated test system for complex research and development applications.
Deep TechDeveloper ToolsEnterprise SoftwareHardware
Daniel Shaddock(CEO)inDanielle Wuchenich(Chief Operating Officer)in
Co-investorsAnzu PartnersBreakthrough VictoriaSignificant VenturesLockheed Martin VenturesMA Growth Ventures
Moku creates Moki, a collection of 8887 hand-assembled NFT characters built from 900+ traits, and develops games around them including an AI Fantasy Arena, a snack-combining puzzler, and an async autobattler.
AI & Machine LearningCrypto & Web3Gaming
Bruce Wasicsko(Founder)in
Co-investorsArca FundsBankless VenturesBig Brain HoldingsBlocktower CapitalContango Digital AssetsFormless Capital+4 more
Neuron23 is a biotech company using data science, human genetics, and functional genomics to develop precision medicines and companion diagnostics for neurodegenerative diseases, starting with an LRRK2 program for Parkinson's disease.
AI & Machine LearningBiotechDeep TechDigital HealthSouth San Francisco, US
Nancy Stagliano(CEO)in
Co-investorsKleiner PerkinsSoftBank GroupSoftBank Vision FundWestlake Village BioPartnersCowen Healthcare InvestmentsHBM Partners+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.